Skip to main content
GILD
NASDAQ Life Sciences

Gilead Acquires Tubulis for $3.15B Upfront, Bolstering Oncology Pipeline

Tom Rudovsky · Reported by Wiseek News
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$131.18
Mkt Cap
$162.025B
52W Low
$104.46
52W High
$157.29
52W Position info
26% above low
Off High info
17% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

GILD sits 26% above its 52-week low of $104.46.

Summary

Gilead Sciences acquired Tubulis for $3.15 billion upfront, with up to $1.85 billion in additional milestones, significantly expanding its oncology pipeline with new ADC platforms and clinical assets. This follows a series of large acquisitions, including the $7.1 billion Arcellx deal, and a recent $3 billion senior notes offering to fund these strategic moves. While bolstering a key growth area, this new acquisition adds to the substantial IPR&D charges that led Gilead to revise its full-year outlook to a net loss. Separately, lab tests indicate Gilead's remdesivir is active against Bundibugyo ebolavirus, potentially broadening its application.

At the time of this announcement, GILD was trading at $131.18 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $162B. The 52-week trading range was $104.46 to $157.29. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

GILD - Latest Insights

GILD
Nov 06, 2026, 12:16 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $167.82
Real-time Price: $167.32 info
Change: -$0.4979 (-0.30%) info
Market Cap: $208.315B info
GILD
Nov 05, 2026, 10:35 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $174.57
Real-time Price: $167.32 info
Change: -$7.25 (-4%) info
Market Cap: $208.315B info
GILD
Oct 29, 2026, 4:03 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $165.88
Real-time Price: $167.32 info
Change: +$1.44 (+0.87%) info
Market Cap: $208.315B info
GILD
Oct 29, 2026, 4:02 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $164.00
Real-time Price: $167.32 info
Change: +$3.32 (+2%) info
Market Cap: $208.315B info
GILD
Oct 22, 2026, 4:05 PM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $157.19
Real-time Price: $167.32 info
Change: +$10.13 (+6%) info
Market Cap: $208.315B info